Clinical Trials Browser

Metastatic Castration-Resistant Prostate Cancer × Docetaxel × Clear all

NCT07287150 2026-03-05

InavoPC

Phase 2 Recruiting

Metastatic Castration-Resistant Prostate Cancer

NCT02861573 2026-02-17

KEYNOTE-365

Phase 1/2 Recruiting

Metastatic Castration-Resistant Prostate Cancer

NCT04666129 2025-08-17

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

Metastatic Castration-Resistant Prostate Cancer